However, we found that the total antioxidant capacity and the capability to mount an antioxidant adaptive response, in part mediated by Nrf2, may enable osteosarcoma cells to withstand G4L-mediated inhibition of cell growth in a cell-type dependent manner. Here, NFE2L2 is linked to osteosarcoma.